Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-12-04

FDA Approved: CANDESARTAN CILEXETIL — Original Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved the original application for candesartan cilexetil from Alembic Pharmaceuticals Limited, enabling a generic version of the antihypertensive drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • candesartan cilexetil (candesartan cilexetil)

Snippet

ORIG AP for CANDESARTAN CILEXETIL (CANDESARTAN CILEXETIL)